関連する実験動画
Updated: Sep 9, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
断続的な喘息と重度の悪化のリスク
Shahid Sheikh1, Mariah Eisner2, Wheaton Kelin3
1Department of Pediatrics, Ohio State University College of Medicine, Columbus, Ohio, USA; Division of Pulmonary Medicine, Columbus, Ohio, USA; Nationwide Children's Hospital, Columbus, Ohio, USA.
Chest
|August 29, 2025
まとめ
軽度の喘息患者のサブグループは,重度の悪化のリスクが非常に低い. 現在のGINAのガイドラインは,この低リスクグループには必要ないし,費用対効果的ではないかもしれません.
科学分野:
- 小児肺科
- 喘息の管理
- 公衆衛生
背景:
- 現在,GINAのガイドラインは,重度の悪化のリスクがあるため,軽度の喘息に対して,短期間のベータアゴニスト (SABA) の単独使用を推奨していません.
- すべての軽度の喘息患者は重度の悪化のリスクが等しいかどうかは不明です.
研究 の 目的:
- 軽度の喘息患者の特定のサブグループが,重度の喘息悪化のリスクが非常に低いかどうかを特定する.
- この特定された低リスクサブグループに対する現在の治療ガイドラインの費用対効果を評価する.
主な方法:
- 2歳から18歳の中断性喘息の集団は オハイオのメディケイドの請求データから 3年以上にわたって特定されました
- 最初の2年間におけるSABAカニスター投与に基づいて,低リスクグループが定義された.
- 3年目は低リスクグループと残りのコホート間の重度の喘息の悪化リスクを比較した.
主要な成果:
- 13,208人の患者は入学基準を満たした. 低リスクグループ (3, 935人の患者) は,年間0~2つのSABAカニスターで,入院率 (0. 08%) とED/UC訪問率 (0. 97%/ 0.55%) が著しく低下しました.
- 比較的入院リスクは0. 17 (IC95%: 0. 06,0. 52) で,重症悪化は0. 18 (IC95%: 0. 13,0. 27) であった.
- 低リスク群の入院を"回防ぐには,5535人の患者が治療され,ICS治療で予防された入院につき779,716ドルの費用がかかりました.
結論:
- 軽度の喘息患者のサブグループが存在し,入院や重度の悪化のリスクが明らかに低い.
- 現在のGINAの第一段階の治療の推奨は,この特定された低リスク集団にとって不要であり,費用対効果的ではないかもしれません.
- リスクの階層化に基づいたパーソナライズされた喘息管理戦略に関するさらなる研究が必要である.
関連する概念動画
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383